tiprankstipranks
Advertisement
Advertisement

Kromek to Meet FY26 Expectations on Strong CBRN and Imaging Demand

Story Highlights
  • Kromek expects FY26 revenue and profit to meet forecasts, driven by stronger CBRN Detection sales and solid Advanced Imaging growth.
  • New orders, resilient demand and mitigated supply chain issues support ongoing momentum and reinforce Kromek’s role in critical detection markets.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Kromek to Meet FY26 Expectations on Strong CBRN and Imaging Demand

Meet Samuel – Your Personal Investing Prophet

An announcement from Kromek Group plc ( (GB:KMK) ) is now available.

Kromek Group expects to report full-year 2026 revenue and profit before tax in line with market expectations, underpinned by increased sales in its CBRN Detection division and solid underlying growth in Advanced Imaging. The performance, supported by £8.8m of new orders in the second half, highlights resilient demand and strengthens the company’s positioning in mission-critical detection applications.

In Advanced Imaging, excluding a prior exceptional Siemens Healthineers agreement, Kromek delivered long-term contracts and mitigated supply chain disruption by securing a major order from an existing customer. The CBRN Detection division also achieved year-on-year revenue growth despite delays in some government procurements, and the Board reports strong momentum as it focuses on executing strategic priorities across both divisions.

Spark’s Take on KMK Stock

According to Spark, TipRanks’ AI Analyst, KMK is a Outperform.

The score is driven primarily by improved financial performance (strong revenue growth, expanding margins, and low leverage), tempered by mixed free cash flow trends. Technicals are supportive due to a strong uptrend and positive MACD, but overbought RSI/Stoch readings add pullback risk. Valuation is moderate on a 20.508 P/E with no dividend yield.

To see Spark’s full report on KMK stock, click here.

More about Kromek Group plc

Kromek Group plc is a UK-headquartered developer of radiation detection and bio-detection technologies serving advanced imaging and CBRN detection markets. The company supplies CZT-based detector components for medical CT and SPECT, security and industrial uses, and provides compact radiation detectors and emerging bio-security systems for global homeland defence and critical infrastructure protection.

Average Trading Volume: 1,786,851

Technical Sentiment Signal: Buy

Current Market Cap: £67.15M

Find detailed analytics on KMK stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1